Acute Lymphoblastic Leukemia News and Research

RSS

Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.

What effect does honey have on human health?

Researchers reviewed existing data on the beneficial impact of honey consumption on human health.

12 Jul 2023

Elevated BMI associated with inferior outcomes to treatment for acute lymphoblastic leukemia

As the United States faces a growing obesity epidemic, scientists are taking a closer look at how body weight can affect health outcomes.

11 Jul 2023

New base-edited T-cells proven effective to treat lymphoblastic leukemia

Three young patients with relapsed T-cell leukemia have now been treated with base-edited T-cells, as part of a 'bench-to-bedside' collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).

15 Jun 2023

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.

5 Jun 2023

Research paves the way to safer, more effective treatment for children with aggressive blood cancers

Australian nanomedicine researchers have come up with a new approach to solving a decades-old clinical problem: getting treatment drugs to act selectively on cancer cells in the body.

18 May 2023

Japanese study finds Cesarean births increase childhood obesity risk

Research investigates the impact of Caesarean section birth on obesity at 3 years of age in Japanese children. The study found that Caesarean birth modestly increases the risk of obesity at 3 years of age in Japanese children.

25 Apr 2023

Children with ALL living in extreme poverty face two-fold greater risk of relapse

Children with acute lymphoblastic leukemia (ALL) who live in extreme poverty and were undergoing maintenance therapy faced an almost two-fold greater risk of relapse compared with kids who weren't as poor, according to a study published in today's issue of Blood.

18 Apr 2023

Study explains why leukemia survivors experience negative effects on blood formation decades later

Contrary to previous belief, stem cells, from which all new blood cells are formed, remain in bone marrow in the blood cancer type acute lymphocytic leukemia.

5 Apr 2023

CAR T-cell therapy improves quality of life for patients with blood cancers

Chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, yet relatively few studies have investigated the impact of the therapy on longitudinal patient quality of life – an aspect of care that often suffers from receiving traditional intensive cancer medications, such as chemotherapy.

30 Mar 2023

Study focuses on new approach that delivers a "one-two punch" to help T cells attack solid tumors

A new approach that delivers a "one-two punch" to help T cells attack solid tumors is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania.

15 Mar 2023

Vitamin A-rich diet may reduce risk of developing asparaginase-associated pancreatitis in ALL patients

Consuming a diet rich in vitamin A or its analogs may help prevent children and young adults with acute lymphoblastic leukemia (ALL) reduce their risk of developing painful pancreas inflammation during chemotherapy treatment.

15 Mar 2023

Personalizing CAR-T cell stimulation during manufacturing can enhance its functionality

New adoptive T cell therapies - in which T cells, the immune system's natural hunters patrolling the body for foreign adversaries, are retrieved from cancer-riddled patients, super-charged and amplified outside the body, and then infused back into the same patient - are changing the prospects of cancer patients.

10 Feb 2023

NUS scientists breathe new life into an existing drug to fight T-cell acute lymphoblastic leukemia

A team of researchers from the Cancer Science Institute of Singapore at the National University of Singapore, led by Associate Professor Takaomi Sanda and Dr Lim Fang Qi, has breathed new life into an existing drug—combatting a type of blood cancer called T-cell acute lymphoblastic leukemia, or T-ALL.

30 Jan 2023

Acute Lymphoblastic Leukemia News and Research

Further Reading

What effect does honey have on human health?

Elevated BMI associated with inferior outcomes to treatment for acute lymphoblastic leukemia

New base-edited T-cells proven effective to treat lymphoblastic leukemia

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Research paves the way to safer, more effective treatment for children with aggressive blood cancers

Japanese study finds Cesarean births increase childhood obesity risk

Children with ALL living in extreme poverty face two-fold greater risk of relapse

Study explains why leukemia survivors experience negative effects on blood formation decades later

CAR T-cell therapy improves quality of life for patients with blood cancers

Study focuses on new approach that delivers a "one-two punch" to help T cells attack solid tumors

Vitamin A-rich diet may reduce risk of developing asparaginase-associated pancreatitis in ALL patients

Personalizing CAR-T cell stimulation during manufacturing can enhance its functionality

NUS scientists breathe new life into an existing drug to fight T-cell acute lymphoblastic leukemia

Researchers develop innovative STAb therapy for a type of leukemia

What is the association between acute lymphoblastic leukemia and congenital cytomegalovirus infection?

Study describes the variations in drug response across genetic subtypes of childhood leukemia

CARxALL clinical trial approved to evaluate CAR-T technology for patients with T-cell leukemia subtype

Novel approach could pave the way for new treatments to prevent relapse in breast cancer patients

Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News